10 June 2025 : Original article
Surgical Complications After Kidney Transplantation
Tímea Blichová ABCDEF 1,2, Patrícia Kleinová C 1,2*, Matej Vnučák CE 1,2, Karol Graňák CE 1,2, Andrej Kollár C 1,2, Jan Svihra Jr. C 3, Juraj Miklušica C 4, Ivana Dedinská ACE 1,2DOI: 10.12659/AOT.948531
Ann Transplant 2025; 30:e948531
Table 6 Multivariant analysis (Cox proportional – hazard regression) – endpoint lymphocele/lymphorrhea.
| End point lymphocele/lymphorrhea | Hazard ratio | 95% CI | P value |
|---|---|---|---|
| Men (%) | 1.0089 | 0.777–1.3091 | 0.9471 |
| Age in time of KT <50 years | 1.2804 | 0.9620–1.7043 | 0.0902 |
| Age in time of KT 50–65 years | 0.7430 | 0.5673–0.9729 | 0.1376 |
| Age in time of KT >65 years | 1.3329 | 0.7622–2.3308 | 0.3136 |
| SCD (%) | 0.7740 | 0.5494–1.0904 | 0.1430 |
| ECD (%) | 1.0819 | 0.7873–1.4867 | 0.6275 |
| LD (%) | 2.6518 | 1.2869–5.4645 | 0.3689 |
| Kidney sent from another center (%) | 0.7663 | 0.5968–0.9838 | 0.1275 |
| Basiliximab induction (%) | 1.3470 | 1.0321–1.7581 | 0.1359 |
| Antithymocyte globulin induction (%) | 0.9912 | 0.7567–1.2984 | 0.9489 |
| Diabetes mellitus (%) | 1.0810 | 0.8339–1.4013 | 0.5565 |
| BMI 25–29.9 kg/m | 1.0930 | 0.2447–4.8835 | 0.9073 |
| BMI >29.9 kg/m | 1.2923 | 0.2366–7.0575 | 0.7672 |
| BK positivity (%) | 0.8984 | 0.5094–1.5846 | 0.7114 |
| Antiplatelet therapy (%) | 0.0707 | 0.0089–0.5616 | 0.0577 |
| Dual antiplatelet therapy (%) | 3.3959 | 1.3046–4.4605 | 0.7251 |
| KT – kidney transplantation; SCD – standard-criteria donor; ECD – extended-criteria donor; LD – living donor; BMI – body mass index. | |||